Atara Biotherapeutics (ATRA) Net Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 603.00 |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 2.25 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 13,865.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 6,876.00 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | -67,094.00 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | -2.38 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 314,889.00 |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | -3,345.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 371.00 |
| 10 | Atara Biotherapeutics | 146.20 Mn | 129.64 Mn | 439,000.00 | -78,088.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -78,088.00 |
| Mar 31, 2026 | -84,202.00 |
| Dec 31, 2025 | -60,250.00 |
| Sep 30, 2025 | -7,010.00 |
| Jun 30, 2025 | 8,009.00 |
| Mar 31, 2025 | 15,479.00 |
| Dec 31, 2024 | 138,879.00 |
| Sep 30, 2024 | 321,008.00 |
| Jun 30, 2024 | 736,379.00 |
| Mar 31, 2024 | 598,271.00 |
| Dec 31, 2023 | 2.87 Mn |
| Sep 30, 2023 | -137,872.00 |
| Jun 30, 2023 | -746,610.00 |
| Mar 31, 2023 | -489,417.00 |
| Dec 31, 2022 | -2.89 Mn |
| Sep 30, 2022 | -30,926.00 |
| Jun 30, 2022 | 220,100.00 |
| Mar 31, 2022 | 100,077.00 |